Casuística
Experiencia inicial con acetato de abiraterona en pacientes con cáncer de próstata resistente a la castración
Initial experience with abiraterone acetate in patients with castration-resistant prostate cancer
Leído
915
Vecesse ha leído el artículo
321
Total PDF
594
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 0 | 2 | 2 |
| 2025 3 | 0 | 1 | 1 |
| 2025 1 | 0 | 1 | 1 |
| 2024 12 | 0 | 1 | 1 |
| 2024 10 | 0 | 1 | 1 |
| 2024 9 | 0 | 3 | 3 |
| 2024 8 | 0 | 6 | 6 |
| 2024 7 | 0 | 1 | 1 |
| 2024 5 | 0 | 1 | 1 |
| 2024 3 | 0 | 2 | 2 |
| 2024 1 | 0 | 1 | 1 |
| 2023 11 | 0 | 1 | 1 |
| 2023 10 | 0 | 2 | 2 |
| 2023 9 | 0 | 2 | 2 |
| 2023 7 | 0 | 4 | 4 |
| 2023 6 | 0 | 1 | 1 |
| 2023 4 | 0 | 1 | 1 |
| 2023 3 | 1 | 0 | 1 |
| 2023 2 | 0 | 2 | 2 |
| 2022 12 | 0 | 2 | 2 |
| 2022 11 | 0 | 2 | 2 |
| 2022 10 | 0 | 4 | 4 |
| 2022 9 | 0 | 4 | 4 |
| 2022 8 | 0 | 5 | 5 |
| 2022 7 | 0 | 3 | 3 |
| 2022 6 | 0 | 5 | 5 |
| 2022 5 | 0 | 3 | 3 |
| 2022 4 | 0 | 2 | 2 |
| 2022 3 | 0 | 5 | 5 |
| 2022 2 | 0 | 1 | 1 |
| 2021 1 | 0 | 1 | 1 |
| 2021 12 | 0 | 4 | 4 |
| 2021 11 | 0 | 3 | 3 |
| 2021 10 | 0 | 2 | 2 |
| 2021 9 | 0 | 4 | 4 |
| 2021 8 | 0 | 1 | 1 |
| 2021 7 | 0 | 2 | 2 |
| 2021 6 | 0 | 3 | 3 |
| 2021 4 | 0 | 1 | 1 |
| 2021 3 | 0 | 3 | 3 |
| 2021 2 | 0 | 3 | 3 |
| 2020 1 | 0 | 2 | 2 |
| 2020 12 | 0 | 6 | 6 |
| 2020 11 | 0 | 2 | 2 |
| 2020 9 | 0 | 1 | 1 |
| 2020 8 | 0 | 4 | 4 |
| 2020 6 | 0 | 1 | 1 |
| 2020 5 | 0 | 4 | 4 |
| 2020 3 | 1 | 8 | 9 |
| 2020 2 | 0 | 3 | 3 |
| 2020 1 | 0 | 5 | 5 |
| 2019 12 | 0 | 1 | 1 |
| 2019 11 | 0 | 1 | 1 |
| 2019 10 | 1 | 2 | 3 |
| 2019 9 | 0 | 4 | 4 |
| 2019 8 | 1 | 2 | 3 |
| 2019 4 | 1 | 0 | 1 |
| 2018 8 | 1 | 0 | 1 |
| 2018 4 | 1 | 0 | 1 |
| 2018 2 | 16 | 0 | 16 |
| 2018 1 | 6 | 0 | 6 |
| 2017 12 | 16 | 1 | 17 |
| 2017 11 | 14 | 2 | 16 |
| 2017 10 | 23 | 4 | 27 |
| 2017 9 | 10 | 4 | 14 |
| 2017 8 | 26 | 1 | 27 |
| 2017 7 | 32 | 2 | 34 |
| 2017 6 | 35 | 9 | 44 |
| 2017 5 | 18 | 16 | 34 |
| 2017 4 | 18 | 8 | 26 |
| 2017 3 | 20 | 15 | 35 |
| 2017 2 | 39 | 9 | 48 |
| 2016 1 | 19 | 5 | 24 |
| 2016 12 | 36 | 11 | 47 |
| 2016 11 | 42 | 8 | 50 |
| 2016 10 | 42 | 21 | 63 |
| 2016 9 | 47 | 5 | 52 |
| 2016 8 | 49 | 4 | 53 |
| 2016 7 | 24 | 1 | 25 |
| 2016 6 | 34 | 16 | 50 |
| 2016 5 | 1 | 11 | 12 |
| 2016 4 | 0 | 2 | 2 |
| 2016 3 | 2 | 2 | 4 |
| 2016 2 | 0 | 1 | 1 |
| 2015 12 | 0 | 2 | 2 |
| 2015 11 | 3 | 1 | 4 |
| 2015 10 | 0 | 1 | 1 |
| 2015 9 | 0 | 2 | 2 |
| 2015 8 | 0 | 1 | 1 |
| 2015 6 | 0 | 2 | 2 |
| 2015 4 | 2 | 0 | 2 |
| 2015 3 | 0 | 2 | 2 |
| 2015 2 | 2 | 0 | 2 |
| 2014 12 | 1 | 0 | 1 |
| 2014 11 | 0 | 1 | 1 |
| 2014 10 | 1 | 0 | 1 |
| 2014 9 | 2 | 3 | 5 |
| 2014 8 | 0 | 1 | 1 |
| 2014 7 | 3 | 1 | 4 |
| 2014 6 | 3 | 2 | 5 |
| 2014 5 | 1 | 2 | 3 |
Mostrar todo
